However, in some cases, it may be prescribed off-label as part of a weight loss plan for patients
There are ongoing legal proceedings and consolidated cases involving certain GLP1 medications, and the landscape continues to develop
A retrospective study conducted at the University Health Network found that, in liver transplant recipients with diabetes, combination therapy reduced HbA1c and alanine aminotransferase levels more effectively than DPP-4 inhibitors. Additionally, two clinical trials in patients with Type 2 diabetes demonstrated that combination therapy significantly lowered HbA1c by 1.34% and 1.21%, compared to a 0.54% reduction with placebo, starting from a baseline of 8.0%. These findings suggest that combination therapy may be especially beneficial in the liver transplant population, where patients often experience weight gain and develop metabolic co-morbidities
What is the difference between glutathione IV therapy and oral supplements
Cumulative life course impairment in vitiligo
Full effects accumulate over the four-week titration phase, so your first dose represents the beginning of a gradual transformation rather than immediate dramatic change
